CONDUIT PHARMACEUTICALS INC. - Common Stock (CDT)

CUSIP: 20678X205

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
11,304,470
Total 13F shares
493,468
Share change
+491,211
Total reported value
$385,113
Price per share
$0.78
Number of holders
31
Value change
+$383,312
Number of buys
29
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 20678X205?
CUSIP 20678X205 identifies CDT - CONDUIT PHARMACEUTICALS INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CONDUIT PHARMACEUTICALS INC. - Common Stock (CDT) as of Q1 2025

As of 31 Mar 2025, CONDUIT PHARMACEUTICALS INC. - Common Stock (CDT) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 493,468 shares. The largest 10 holders included AQR CAPITAL MANAGEMENT LLC, STATE STREET CORP, UBS Group AG, Vanguard Personalized Indexing Management, LLC, Squarepoint Ops LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, GOLDMAN SACHS GROUP INC, and MORGAN STANLEY. This page lists 31 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.